Spots Global Cancer Trial Database for Biological Factors Predicting Response to Chemotherapy in Advanced Non Small Cell Lung Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Biological Factors Predicting Response to Chemotherapy in Advanced Non Small Cell Lung Cancer
Official Title: Biological Factors Predicting Response to Chemotherapy in Advanced Non Small Cell Lung Cancer : a Prospective Study
Study ID: NCT00864266
Conditions
Interventions
Study Description
Brief Summary: The primary aim of the study is to identify a predictive molecular signature for response to chemotherapy, according to WHO criteria, in patients with non-small cell lung cancer by studying the transcriptome (miRNAs and mRNAs) and the single nucleotide polymorphism (SNPs) by using high throughput techniques.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Department of Pneumology Clinique Saint-Luc, Bouge, , Belgium
Department of Intensive Care Unit and Thoracic Oncology Institut Jules Bordet, Brussels, , Belgium
Service de Pneumologie H么pital Erasme, Brussels, , Belgium
Department of Pneumology H么pital Saint-Joseph, Gilly, , Belgium
H么pital Ambroise Par茅, Mons, , Belgium
Department of Pneumology Centre Hospitalier de Mouscron, Mouscron, , Belgium
Contact Details
Name: Thierry Berghmans, MD
Affiliation: European Lung Cancer Working Party
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
